Literature DB >> 26567611

Current status and future perspectives of fluorescence-guided surgery for cancer.

Jonathan C DeLong1, Robert M Hoffman1,2, Michael Bouvet1.   

Abstract

Curative cancer surgery is dependent on the removal of all primary tumor and metastatic cancer cells. Preoperative imaging, intraoperative inspection and palpation, as well as pathological margin confirmation aid the surgeon, but these methods are lacking in sensitivity and can be highly subjective. Techniques in fluorescence-guided surgery (FGS) are emerging that selectively illuminate cancer cells, enhancing the distinction between tumors and surrounding tissues with the potential for single-cell sensitivity. FGS enhances tumor detection, surgical navigation, margin confirmation, and in some cases can be combined with therapeutic techniques to eliminate microscopic disease. In this review, we describe the preclinical developments and currently-used techniques for FGS.

Entities:  

Keywords:  Fluorescence-guided surgery (FGS); fluorescent proteins; fluorophore; photoimmunotherapy; theranostics

Mesh:

Substances:

Year:  2015        PMID: 26567611      PMCID: PMC5572645          DOI: 10.1586/14737140.2016.1121109

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  96 in total

1.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

2.  Comparison of a chimeric anti-carcinoembryonic antigen antibody conjugated with visible or near-infrared fluorescent dyes for imaging pancreatic cancer in orthotopic nude mouse models.

Authors:  Ali A Maawy; Yukihiko Hiroshima; Sharmeela Kaushal; George A Luiken; Robert M Hoffman; Michael Bouvet
Journal:  J Biomed Opt       Date:  2013-12       Impact factor: 3.170

3.  Glowing tumors make for better detection and resection.

Authors:  Michael Bouvet; Robert M Hoffman
Journal:  Sci Transl Med       Date:  2011-11-23       Impact factor: 17.956

4.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides.

Authors:  Tao Jiang; Emilia S Olson; Quyen T Nguyen; Melinda Roy; Patricia A Jennings; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

Review 5.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

6.  Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.

Authors:  B M Stiles; P S Adusumilli; A Bhargava; S F Stanziale; T H Kim; M-K Chan; R Huq; R Wong; V W Rusch; Y Fong
Journal:  Cancer Gene Ther       Date:  2006-01-01       Impact factor: 5.987

7.  Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy.

Authors:  Kristin E Bullok; Mary Dyszlewski; Julie L Prior; Christina M Pica; Vijay Sharma; David Piwnica-Worms
Journal:  Bioconjug Chem       Date:  2002 Nov-Dec       Impact factor: 4.774

Review 8.  Carcinoembryonic antigen (CEA) in clinical medicine: historical perspectives, pitfalls and projections.

Authors:  P Gold; J Shuster; S O Freedman
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

Review 9.  Epidermal growth factor receptor imaging in human head and neck cancer xenografts.

Authors:  Laura K van Dijk; Otto C Boerman; Johannes H A M Kaanders; Johan Bussink
Journal:  Acta Oncol       Date:  2015-08-06       Impact factor: 4.089

10.  Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.

Authors:  Yukihiko Hiroshima; Ali Maawy; Yong Zhang; Takashi Murakami; Masashi Momiyama; Ryutaro Mori; Ryusei Matsuyama; Matthew H G Katz; Jason B Fleming; Takashi Chishima; Kuniya Tanaka; Yasushi Ichikawa; Itaru Endo; Robert M Hoffman; Michael Bouvet
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

View more
  16 in total

1.  SAGES Technology and Value Assessment Committee safety and effectiveness analysis on immunofluorescence in the operating room for biliary visualization and perfusion assessment.

Authors:  Bryan J Sandler; Danny Sherwinter; Lucian Panait; Richard Parent; Jennifer Schwartz; David Renton
Journal:  Surg Endosc       Date:  2017-06-22       Impact factor: 4.584

2.  Affibody-targeted fluorogen activating protein for in vivo tumor imaging.

Authors:  Yi Wang; Byron Ballou; Brigitte F Schmidt; Sue Andreko; Claudette M St Croix; Simon C Watkins; Marcel P Bruchez
Journal:  Chem Commun (Camb)       Date:  2017-02-07       Impact factor: 6.222

Review 3.  Improving theranostics in pancreatic cancer.

Authors:  Jeremy King; Michael Bouvet; Gagandeep Singh; John Williams
Journal:  J Surg Oncol       Date:  2017-05-17       Impact factor: 3.454

Review 4.  Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2018-08-06       Impact factor: 3.454

5.  Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.

Authors:  Jonathan C DeLong; Takashi Murakami; Paul J Yazaki; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Res       Date:  2017-10       Impact factor: 2.192

6.  Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.

Authors:  Thinzar M Lwin; Sophie Hernot; Hannah Hollandsworth; Siamak Amirfakhri; Filemoni Filemoni; Pieterjan Debie; Robert M Hoffman; Michael Bouvet
Journal:  Surgery       Date:  2020-05-04       Impact factor: 3.982

Review 7.  Fluorescence-Guided Surgery.

Authors:  Tadanobu Nagaya; Yu A Nakamura; Peter L Choyke; Hisataka Kobayashi
Journal:  Front Oncol       Date:  2017-12-22       Impact factor: 6.244

Review 8.  Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.

Authors:  Shyam S Mohapatra; Surinder K Batra; Srinivas Bharadwaj; Michael Bouvet; Bard Cosman; Ajay Goel; Wilma Jogunoori; Michael J Kelley; Lopa Mishra; Bibhuti Mishra; Subhra Mohapatra; Bhaumik Patel; Joseph R Pisegna; Jean-Pierre Raufman; Shuyun Rao; Hemant Roy; Maren Scheuner; Satish Singh; Gitanjali Vidyarthi; Jon White
Journal:  Dig Dis Sci       Date:  2018-03-23       Impact factor: 3.199

9.  Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW.

Authors:  Marti Boss; Desiree Bos; Cathelijne Frielink; Gerwin Sandker; Selen Ekim; Camille Marciniak; Francois Pattou; Go van Dam; Sanne van Lith; Maarten Brom; Martin Gotthardt; Mijke Buitinga
Journal:  J Nucl Med       Date:  2020-01-10       Impact factor: 11.082

10.  Combined application of Indocyanine green (ICG) and laser lead to targeted tumor cell destruction.

Authors:  Jordan S Taylor; Jasmine Zeki; Naohiko Ikegaki; Liaohai L Chen; Bill Chiu
Journal:  J Pediatr Surg       Date:  2018-09-04       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.